Celularity and CH Trading Group Announce Territory Distribution Agreement for the Middle East

FLORHAM PARK, N.J. & RIYADH, Saudi Arabia & JEDDAH, Saudi Arabia — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC (“CH Trading Group”), an international import, export and trading company, today announced that they have enteredContinue Reading